Business Context and Reporting Period
This Form 8-K Current Report was filed by AAR CORP. on October 5, 2020. The filing addresses the termination of a poison pill defense mechanism (Rights Agreement) originally adopted on March 27, 2020, and the subsequent elimination of the associated Series A Junior Participating Preferred Stock.
Key Financial Metrics
This filing is a current report regarding corporate governance and capital structure changes. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial performance metrics.
Material Changes
- Termination of Rights Agreement: On October 5, 2020, the Company and Computershare Trust Company, N.A. entered into an Amendment and Termination to the Rights Agreement. This action accelerated the expiration of the Rights from February 28, 2021, to October 5, 2020.
- Expiration of Rights: At the close of business on October 5, 2020, the preferred share purchase rights expired and are no longer outstanding.
- Elimination of Preferred Stock: The Company filed a Certificate of Elimination with the Delaware Secretary of State, removing the Series A Junior Participating Preferred Stock from the Restated Certificate of Incorporation. No shares of this Preferred Stock were issued or outstanding at the time of filing.
Management Commentary and Rationale
The Board of Directors decided to terminate the Rights Agreement after evaluating current market conditions relative to the time of the agreement's adoption. Additionally, the Board received objections from a large institutional stockholder regarding the adoption of the Rights Agreement. The termination was executed to return the Preferred Stock to authorized but undesignated shares.
Investor Verification Checklist
- Verify the effective date of the Rights Agreement termination (October 5, 2020).
- Confirm that no shares of Series A Junior Participating Preferred Stock were issued or outstanding.
- Review the full text of the Amendment and Termination (Exhibit 4.1) for any residual obligations.
- Check the Certificate of Elimination (Exhibit 3.1) to confirm the status of the Company's authorized preferred stock.